Debate on Marijuana Research and Regulations

The chapter discusses the heated debate surrounding the lack of placebo-controlled clinical trials on marijuana legalization, highlighting the challenges in conducting FDA-approved studies due to past government monopolies and licensing restrictions. It addresses the limitations of cannabis research in the US, emphasizing the impact on veterans' access to medical cannabis at VA facilities. Additionally, the chapter explores the potential benefits of moving marijuana from Schedule I to Schedule III for easier research processes, FDA approvals, and tax breaks for companies.